Parvovirus B19 Rebound
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Stefania Ranno und 14 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Parvovirus B19, Human, Parvoviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Italian Ministry of Health with "Current Research funds.".
Abstract (Originalsprache)
Human parvovirus B19 (B19V) is responsible for a wide clinical spectrum ranging from asymptomatic infection, through mild disease, up to life‐threatening one. Outbreaks are registered every 3–4 years, and a recent international alert for a new outbreak has been released. The experience of B19 virus circulation in a 600‐bed tertiary care pediatric hospital in Rome from 2018 to 2024 is reported here. This retrospective study involved a total of 9695 blood samples (about 8500 patients), 11 amniotic fluids (11 pregnant women), and 10 827 sera (about 9500 patients), processed in the Virology Unit of Bambino Gesù Children's Hospital in Rome for B19V direct and indirect detection. In our population, the annual positivity rate for B19V DNA ranged from 0.8% in 2023 to 9.8% in 2018 and 32.8% in 2024; the same trend resulted from the analysis of the immunoglobulins M and G anti‐B19V. Focusing on the last year, 314 patients resulted positive for B19V DNA detection: 204/314 (65%) had a primary infection, 150/204 (73.5%) were hospitalized, and 17/150 (11.3%) needed Intensive Care Unit (ICU) for cardiovascular, central nervous, and gastrointestinal pathologies. Two patients died from myocarditis. Among patients with the most severe clinical picture, over half had no concurring disease, and one patient died. Four amniotic fluids were positive for pregnant women who came to our observation. B19V typing of a subset of samples revealed the presence of only subtype 1A and a low intragenotypic diversity between strains from severe and mild disease. In conclusion, in 2024, a significant increase in B19V circulation was observed with profound effects on clinical outcome and consequent hospitalisation, either in patients with comorbidities or those without. This widespread circulation of the virus also had an impact on infections in pregnancy, with the known severe consequences for unborn children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Pediatric Emergency Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Pediatrics Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Fetal Medicine and Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Stefania Ranno, Luana Coltella
Förderung
- This work was supported by the Italian Ministry of Health with "Current Research funds."
Zitieren
APA
Ranno, S., Russo, C., Colagrossi, L., Fox, V., Di Maio, V. C., Linardos, G., Gentile, L., Marotta, R., Cristaldi, S., Campana, A., Pisani, M., Caforio, L., Villani, A., Perno, C. F., & Coltella, L. (2025). Parvovirus B19 Rebound. Journal of Medical Virology. https://doi.org/10.1002/jmv.70380
Vancouver
Ranno S, Russo C, Colagrossi L, Fox V, Di Maio VC, Linardos G, et al. Parvovirus B19 Rebound. Journal of Medical Virology. 2025. doi:10.1002/jmv.70380
BibTeX
@article{Ranno2025,
author = {Ranno, Stefania and Russo, Cristina and Colagrossi, Luna and Fox, Valeria and Di Maio, Velia Chiara and Linardos, Giulia and Gentile, Leonarda and Marotta, Rosaria and Cristaldi, Sebastian and Campana, Andrea and Pisani, Mara and Caforio, Leonardo and Villani, Alberto and Perno, Carlo Federico and Coltella, Luana},
title = {Parvovirus B19 Rebound},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70380}
}
EUVIMED